A new genetic target could shape the future of liver cancer treatment
Credit: Hepatology (2025). DOI: 10.1097/HEP.0000000000001406 Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of...
Credit: Hepatology (2025). DOI: 10.1097/HEP.0000000000001406 Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of...
NHS patients will be the first in Europe to benefit from a groundbreaking cancer treatment that destroys tumours using sound.The...
Sean Ronnekleiv-Kelly, MD Division of Surgical Oncology Associate Professor Sean Ronnekleiv-Kelly, MD, is determined to improve treatment options for a...
Single-cell RNA sequencing identifies FABP5 upregulation during HCC progression. Credit: Nature Metabolism (2024). DOI: 10.1038/s42255-024-01019-6 Metabolic diseases like obesity can...
Metabolic diseases like obesity can increase the risk of developing liver cancer, research has shown. But how one disease predisposes...
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease...